New Thematic Series: Obstructive Sleep Apnoea Syndrome
Obstructive sleep apnea syndrome (OSAS) is an an underdiagnosed chronic disease characterized by recurrent episodes of apneas and hypopneas during sleep, associated with repetitive episodes of intermittent hypoxemia, intrathoracic pressure changes, arousals, and excessive daytime sleepiness. OSAS is considered as risk factor for cancer. Patients with untreated OSAS are at significantly increased risk of cardiovascular, metabolic, neurocognitive disease and motor vehicle accidents (MVAs). The European Commission recommended mandatory testing for OSAS, before a driver's license is granted or renewed.
This collection provides the newest research, comprehensive background information and up-to-date information on obstructive sleep apnea syndrome.
Call for papers: If you wish to submit your manuscript on obstructive sleep apnea syndrome (OSAS), please follow the instructions and submit your manuscript in Editorial Manager. Please select the thematic series upon submission.
Aims and scope
Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research.
The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.
Given the journal’s interdisciplinary character, the target readership is wider than respiratory medicine, embracing numerous related disciplines (allergology, immunology, internal medicine, geriatrics, infectious diseases, intensive care, etc) and health professionals.
You can read the supplement here.
Discounts for BioMed Central members
BioMed Central has a total of 522 Members across 56 countries, including 14 Italian institutions. Members can benefit from discounted or waived article processing charges (APCs) when publishing in Multidisciplinary Respiratory Medicine. Click here to find out more about our member institutions.
Sign up to receive article alerts
Multidisciplinary Respiratory Medicine is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.
Featured review: Recent advances in capsule-based dry powder inhaler technology
Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in the lungs. Among the available delivery options, the dry powder inhaler (DPI) is the preferred device for the treatment of an increasingly diverse range of diseases. This article reviews recent advances in capsule-based DPI technology and the introduction of the ‘disposable’ DPI device.
Featured article: Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice
The intratracheal instillation of bleomycin in mice induces early damage to alveolar epithelial cells and development of inflammation followed by fibrotic tissue changes. Histopathology is the gold standard for assessing lung fibrosis in rodents, however it precludes repeated and longitudinal measurements of disease progression. This study investigates the use of the Micro-CT technique to allow the evaluation of disease onset and progression at different time-points in the mouse bleomycin model of lung fibrosis.
Official journal of
The official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP)
2017 Journal Metrics
55 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
86 days from submission to acceptance
47 days from acceptance to publication
0.838 - Source Normalized Impact per Paper (SNIP)
1.13 - SCImago Journal Rank (SJR)
1.76 - Citescore
192 Altmetric mentions